Overview
- 40 inspections across 38 sites are on record.
- 64 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-27.
At a glance
Inspections
40
Sites
38
Observations
64
Career since
Apr 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Amgen Manufacturing Limited LLC | 27 Apr 2026 | Human Drugs | On file |
| Maiva Pharma Private Limited | 20 Feb 2026 | Human Drugs | On file |
| BioMylz Pvt. Ltd. | 9 Feb 2026 | Human Drugs | On file |
| Global Calcium Pvt. Limited | 3 Feb 2026 | Human Drugs | On file |
| Alchymars ICM SM Private Limited | 4 Dec 2025 | Human Drugs | On file |
Sites inspected
Amgen Manufacturing Limited LLCJuncos, United States1 insp.
Maiva Pharma Private LimitedHosur, India1 insp.
BioMylz Pvt. Ltd.Bengaluru, India1 insp.
Global Calcium Pvt. LimitedHosur, India1 insp.
Alchymars ICM SM Private LimitedAlathur, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Marian E Ramirez10 shared
Angelica M Hernandez9 shared
Jose E Melendez4 shared
Chad W Rice3 shared
Anastasia M Shields2 shared
Pratik S Upadhyay2 shared
Jose F Velez2 shared
Santos E Camara1 shared
Samantha E Cleek1 shared
Megan T Ziegler1 shared
Full investigator report
Get the verbatim findings behind Alan A Rivera's 64 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site